This is a Validated Antibody Database (VAD) review about
human FGFR2, based on 19 published articles (
read how Labome selects the articles), using FGFR2 antibody in all methods. It is aimed to help Labome visitors find the most suited FGFR2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
FGFR2 synonym: BBDS; BEK; BFR-1; CD332; CEK3; CFD1; ECT1; JWS; K-SAM; KGFR; TK14; TK25
Abcam
domestic rabbit monoclonal (EPR5180) | - western blot; human; 1:500; loading ...; fig 2k
| Abcam FGFR2 antibody (Abcam, ab109372) was used in western blot on human samples at 1:500 (fig 2k). Aging (Albany NY) (2021) ncbi |
domestic rabbit polyclonal | - immunohistochemistry - paraffin section; mouse; 1:300; loading ...; fig 5b
- western blot; mouse; loading ...; fig 5c
| Abcam FGFR2 antibody (Abcam, ab10648) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 5b) and in western blot on mouse samples (fig 5c). Evid Based Complement Alternat Med (2020) ncbi |
domestic rabbit polyclonal | - immunohistochemistry - paraffin section; human; 1:1000; loading ...; fig 1b
| Abcam FGFR2 antibody (Abcam, ab10648) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 1b). PLoS ONE (2020) ncbi |
domestic rabbit polyclonal | - immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 4a
| Abcam FGFR2 antibody (Abcam, ab10648) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 4a). Stem Cells Transl Med (2019) ncbi |
domestic rabbit polyclonal | - flow cytometry; mouse; loading ...; fig st1
| In order to study how bone marrow endothelial cells regulate bone marrow stem cell maintenance and leukocyte trafficking, Abcam FGFR2 antibody (Abcam, Ab10648) was used in flow cytometry on mouse samples (fig st1). Nature (2016) ncbi |
domestic rabbit polyclonal | - immunocytochemistry; rat; fig 7
- western blot; rat; 1:2000; fig 7
| Abcam FGFR2 antibody (abcam, ab10648) was used in immunocytochemistry on rat samples (fig 7) and in western blot on rat samples at 1:2000 (fig 7). Sci Rep (2016) ncbi |
Abnova
mouse monoclonal (1G3) | - immunohistochemistry - paraffin section; human; loading ...; fig 2d
| Abnova FGFR2 antibody (Abnova, H00002263-M01) was used in immunohistochemistry - paraffin section on human samples (fig 2d). Cancers (Basel) (2020) ncbi |
mouse monoclonal (1G3) | - immunohistochemistry - paraffin section; human; 1:600; loading ...; fig 6c, 6d
| Abnova FGFR2 antibody (Abnova, H00002263-M01) was used in immunohistochemistry - paraffin section on human samples at 1:600 (fig 6c, 6d). Oncotarget (2016) ncbi |
mouse monoclonal (1G3) | - immunohistochemistry - paraffin section; human; 1:3000; tbl 1
| Abnova FGFR2 antibody (Abnova, H2263-M01) was used in immunohistochemistry - paraffin section on human samples at 1:3000 (tbl 1). Cancer Res Treat (2016) ncbi |
mouse monoclonal (1G3) | - immunohistochemistry - paraffin section; human; 1:500; fig 5
| Abnova FGFR2 antibody (Abnova, H00002263-M01) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 5). J Stroke Cerebrovasc Dis (2014) ncbi |
Santa Cruz Biotechnology
mouse monoclonal (C-8) | - western blot; mouse; loading ...; fig 6a
| Santa Cruz Biotechnology FGFR2 antibody (Santa Cruz, sc-6930) was used in western blot on mouse samples (fig 6a). Int J Mol Sci (2021) ncbi |
mouse monoclonal (C-8) | - western blot; human; 1:500; loading ...; fig 4b
| Santa Cruz Biotechnology FGFR2 antibody (SantaCruz, sc-6930) was used in western blot on human samples at 1:500 (fig 4b). Oncol Lett (2017) ncbi |
mouse monoclonal (C-8) | - immunocytochemistry; human; loading ...; fig 5b
- western blot; human; loading ...; fig 5a
| Santa Cruz Biotechnology FGFR2 antibody (Santa Cruz Biotechnology, sc-6930) was used in immunocytochemistry on human samples (fig 5b) and in western blot on human samples (fig 5a). Mol Cell Biochem (2015) ncbi |
Invitrogen
domestic rabbit polyclonal | - western blot; mouse; 1:1000; loading ...; fig 2e, 2f
| Invitrogen FGFR2 antibody (Thermo Fisher, PA5-64796) was used in western blot on mouse samples at 1:1000 (fig 2e, 2f). Sci Rep (2020) ncbi |
domestic rabbit polyclonal | - western blot; mouse; 1:1000; loading ...; fig 2e, 2f
| Invitrogen FGFR2 antibody (Thermo Fisher, PA5-14651) was used in western blot on mouse samples at 1:1000 (fig 2e, 2f). Sci Rep (2020) ncbi |
Cell Signaling Technology
domestic rabbit monoclonal (C51F2) | - western blot; human; loading ...; fig 4b
| Cell Signaling Technology FGFR2 antibody (Cell Signaling, 4574) was used in western blot on human samples (fig 4b). J Exp Clin Cancer Res (2019) ncbi |
domestic rabbit monoclonal (D4L2V) | - western blot; human; loading ...; fig 3b
| Cell Signaling Technology FGFR2 antibody (Cell Signaling Technology, 23328) was used in western blot on human samples (fig 3b). Breast Cancer Res (2019) ncbi |
domestic rabbit monoclonal (C51F2) | - immunohistochemistry; human; fig 6a
- western blot; human; fig 4a
| Cell Signaling Technology FGFR2 antibody (Cell Signaling, C51F2) was used in immunohistochemistry on human samples (fig 6a) and in western blot on human samples (fig 4a). Oncotarget (2015) ncbi |
domestic rabbit monoclonal (C51F2) | | Cell Signaling Technology FGFR2 antibody (Cell Signaling, 4574) was used in western blot on human samples . J Thyroid Res (2014) ncbi |
domestic rabbit monoclonal (C51F2) | | In order to study mechanism of resistance to the FGFR inhibitor BGJ398 and the FGFR inhibitor ponatinib, Cell Signaling Technology FGFR2 antibody (cell signaling, 4574S) was used in western blot on human samples . Oncogene (2015) ncbi |
Rajendran R, Rajendran V, Giraldo Velasquez M, Megalofonou F, Gurski F, Stadelmann C,
et al. Oligodendrocyte-Specific Deletion of FGFR1 Reduces Cerebellar Inflammation and Neurodegeneration in MOG35-55-Induced EAE. Int J Mol Sci. 2021;22:
pubmed publisher
Guo T, Gu C, Li B, Xu C. Dual inhibition of FGFR4 and BCL-xL inhibits multi-resistant ovarian cancer with BCL2L1 gain. Aging (Albany NY). 2021;13:19750-19759
pubmed publisher
Braun M, Piasecka D, Tomasik B, Mieczkowski K, Stawiski K, Zielińska A,
et al. Hormonal Receptor Status Determines Prognostic Significance of FGFR2 in Invasive Breast Carcinoma. Cancers (Basel). 2020;12:
pubmed publisher
Wang Y, Liao Q, Tang S, Cai Z, Zhang H. Gubenzhike Recipe Ameliorates Respiratory Mucosal Immunity in Mice with Chronic Obstructive Pulmonary Disease through Upregulation of the γδT Lymphocytes and KGF Levels. Evid Based Complement Alternat Med. 2020;2020:3056797
pubmed publisher
Ichikawa K, Watanabe Miyano S, Minoshima Y, Matsui J, Funahashi Y. Activated FGF2 signaling pathway in tumor vasculature is essential for acquired resistance to anti-VEGF therapy. Sci Rep. 2020;10:2939
pubmed publisher
Jun B, Lee W, Jang J, Jeong S, Chang Y, Lee S,
et al. Relation of fibroblast growth factor receptor 2 expression to hepatocellular carcinoma recurrence after liver resection. PLoS ONE. 2020;15:e0227440
pubmed publisher
Si J, Ma Y, Bi J, Xiong Y, Lv C, Li S,
et al. Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties. J Exp Clin Cancer Res. 2019;38:481
pubmed publisher
Villani V, Thornton M, Zook H, Crook C, Grubbs B, Orlando G,
et al. SOX9+/PTF1A+ Cells Define the Tip Progenitor Cells of the Human Fetal Pancreas of the Second Trimester. Stem Cells Transl Med. 2019;8:1249-1264
pubmed publisher
Hori A, Shimoda M, Naoi Y, Kagara N, Tanei T, Miyake T,
et al. Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer. Breast Cancer Res. 2019;21:88
pubmed publisher
Yang W, Wang X, Yuan H, Liu Z, Gao S, Peng L. Exploring the mechanism of WWOX growth inhibitory effects on oral squamous cell carcinoma. Oncol Lett. 2017;13:3198-3204
pubmed publisher
Piasecka D, Kitowska K, Czaplinska D, Mieczkowski K, Mieszkowska M, Turczyk L,
et al. Fibroblast growth factor signalling induces loss of progesterone receptor in breast cancer cells. Oncotarget. 2016;7:86011-86025
pubmed publisher
Itkin T, Gur Cohen S, Spencer J, Schajnovitz A, Ramasamy S, Kusumbe A,
et al. Distinct bone marrow blood vessels differentially regulate haematopoiesis. Nature. 2016;532:323-8
pubmed publisher
Tong L, Zhou J, Rong L, Seeley E, Pan J, Zhu X,
et al. Fibroblast Growth Factor-10 (FGF-10) Mobilizes Lung-resident Mesenchymal Stem Cells and Protects Against Acute Lung Injury. Sci Rep. 2016;6:21642
pubmed publisher
Inaguma S, Ito H, Riku M, Ikeda H, Kasai K. Addiction of pancreatic cancer cells to zinc-finger transcription factor ZIC2. Oncotarget. 2015;6:28257-68
pubmed publisher
Litwin M, Radwańska A, Paprocka M, Kieda C, Dobosz T, Witkiewicz W,
et al. The role of FGF2 in migration and tubulogenesis of endothelial progenitor cells in relation to pro-angiogenic growth factor production. Mol Cell Biochem. 2015;410:131-42
pubmed publisher
Park S, Nam S, Keam B, Kim T, Jeon Y, Lee S,
et al. VEGF and Ki-67 Overexpression in Predicting Poor Overall Survival in Adenoid Cystic Carcinoma. Cancer Res Treat. 2016;48:518-26
pubmed publisher
Tohyama O, Matsui J, Kodama K, Hata Sugi N, Kimura T, Okamoto K,
et al. Antitumor activity of lenvatinib (e7080): an angiogenesis inhibitor that targets multiple receptor tyrosine kinases in preclinical human thyroid cancer models. J Thyroid Res. 2014;2014:638747
pubmed publisher
Wang J, Mikse O, Liao R, Li Y, Tan L, Jänne P,
et al. Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells. Oncogene. 2015;34:2167-77
pubmed publisher
Katano H, Yamada K. Upregulation of ANGPTL4 messenger RNA and protein in severely calcified carotid plaques. J Stroke Cerebrovasc Dis. 2014;23:933-47
pubmed publisher
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.